This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

N. Warren Hindle, MD
Calgary, Alberta

Arch Ophthalmol. 1995;113(6):697-698.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

An acceptable outcome of retinopathy of prematurity (ROP), whether natural or after treatment, is not synonymous with the experimentally designated "favorable outcome" of the Multicenter Trial of Cryotherapy for ROP.¹ Whereas their outcome grade II—macular displacement—must include eyes with significant visual disability, surely the goal of treatment should be the prevention of macular displacement.

In Table 3 of the report by the Cryotherapy for Retinopathy of Prematurity Cooperative group,¹ eight of 93 eyes that had one to four sectors of stage 3+ ROP in zone II had the study's unfavorable result, ie, a retinal fold involving the macula or worse. Outcomes of an additional six eyes were considered favorable, but these eyes may be visually disabled because of macular displacement, which would be unacceptable to ophthalmologists, parents, and patients.

If all the data were provided, ie, a breakdown of outcome from eyes with 1, 2, 3, or 4 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?